RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2033
상품코드:1480364
리서치사:The Business Research Company
발행일:2024년 05월
페이지 정보:영문 294 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 RNA 표적 저분자 치료제 시장은 13억 4,630만 달러로 평가되며, 2023년까지 CAGR 28.0% 이상으로 성장했습니다.
신경질환의 발생률 증가
신경질환의 이환율 증가는 역사적 기간에 RNA 표적 저분자 Drug Discovery 시장의 성장을 촉진했습니다. 신경질환은 뇌, 척수, 신경을 포함한 신경계에 영향을 미쳐 운동, 감각, 인지 및 기타 신경 기능에 장애를 초래하는 광범위한 질환을 말합니다. 인구 고령화, 환경오염물질, 생활습관의 변화, 진단 능력의 향상으로 인해 이전에는 발견되지 않았던 질환이 발견되는 등 신경질환의 발생률이 증가하고 있으며, RNA 표적 저분자 신약개발은 신경질환의 병태생리와 관련된 RNA 분자를 특이적으로 표적으로 하는 치료제를 개발함으로써 신경질환에 대한 대처를 돕고, 질환의 진행을 조절하는 새로운 치료법을 제공할 수 있습니다. 영국에 본사를 둔 생물 의학 연구 기관인 국립보건연구원에 따르면 2019년 신경질환은 전 세계 질병 부담의 3.8%, 호주의 질병 부담의 6.6%를 차지했으며, 2022년에는 신경질환이 질병 부담의 8%를 차지할 것으로 예상했습니다. 따라서 신경 질환의 발생률 증가는 RNA 표적 저분자 치료제 시장의 성장을 주도했습니다.
목차
제1장 주요 요약
RNA 표적 저분자 치료제 - 시장의 매력과 거시경제 상황
제2장 목차
제3장 표 리스트
제4장 도표 리스트
제5장 리포트 구성
제6장 시장의 특징
일반적인 시장의 정의
개요
RNA 표적 저분자 치료제 시장 정의와 세분화
제품별 : 시장 세분화
안티센스 올리고뉴클레오티드(ASO)
siRNA
치료 적응증별 : 시장 세분화
근골격 장애
신경변성질환
순환기 질환
비뇨생식기
기타 치료 적응증
최종사용자별 : 시장 세분화
병원
조사실
제약 및 바이오테크놀러지 기업
기타 최종사용자
제7장 주요 시장 동향
RNA 표적 저분자 치료제를 추진하는 전략적 협업
주요 기업이 RNA 표적 저분자 치료에서 스타트업 솔루션을 채택
Drug Discovery에서 RNA 표적 저분자의 효율을 높이기 위한 인공지능(AI)의 이용
RNA를 표적으로 한 저분자 치료에서 혁신을 추진하는 파트너십
다양한 의료 분야를 타깃으로 한 RNA 분해 치료제의 진보에 초점을 맞춘다.
mRNA 소분자 Drug Discovery에 대한 주목의 증가
신경질환 치료를 위한 RNA 조절약의 개발
제8장 RNA 표적 저분자 치료제 시장 : 거시경제 시나리오
COVID-19의 영향 : RNA 표적 저분자 치료제 시장
우크라이나 전쟁의 영향 : RNA 표적 저분자 치료제 시장
고인플레이션의 영향 : RNA 표적 저분자 치료제 시장
제9장 세계 시장 규모와 성장
시장 규모
시장 성장 실적, 2018-2023
시장 촉진요인 2018-2023
시장 억제요인 2018-2023
시장 성장 예측, 2023-2028, 2033F
시장 촉진요인 2023-2028
시장 억제요인 2023-2028
제10장 세계의 RNA 표적 저분자 치료제 시장 : 세분화
세계의 RNA 표적 저분자 치료제 시장 : 유형별, 실적과 예측, 2018-2023, 2028F, 2033F
세계의 RNA 표적 저분자 치료제 시장 : 치료 적응증별, 실적과 예측, 2018-2023, 2028F, 2033F
세계의 RNA 표적 저분자 치료제 시장 : 최종사용자별, 실적과 예측, 2018-2023, 2028F, 2033F
제11장 RNA 표적 저분자 치료제 시장 : 지역·국가별 분석
세계의 RNA 표적 저분자 치료제 시장 : 지역별, 실적과 예측, 2018-2023, 2028F, 2033F
세계의 RNA 표적 저분자 치료제 시장 : 국가별, 실적과 예측, 2018-2023, 2028F, 2033F
제12장 아시아태평양 시장
제13장 서유럽 시장
제14장 동유럽 시장
제15장 북미 시장
제16장 남미 시장
제17장 중동 시장
제18장 아프리카 시장
제19장 경쟁 구도와 기업 개요
기업 개요
Ionis Pharmaceuticals
Alnylam Pharmaceuticals
Sarepta Therapeutics
Jazz Pharmaceuticals
Novartis
제20장 기타 대기업과 혁신적 기업
NS Pharma
Arrakis Therapeutics
PTC Therapeutics
Anima Biotech Inc.
Ribometrix
Skyhawk Therapeutics Inc.
STORM Therapeutics Ltd.
Accent Therapeutics
Promega Corporation
Bayer AG
Arrowhead Pharmaceuticals Inc.
Abivax SA
AC Immune SA
Remix Therapeutics
858 Therapeutics
제21장 경쟁 벤치마킹
제22장 경쟁 대시보드
제23장 주요 합병과 인수
Novo Nordisk Acquire DiceRNA Pharmaceuticals
Sanofi's Acquired Translate Bio
제24장 기회와 전략
2028년의 세계 RNA 표적 저분자 치료제 시장 : 새로운 기회가 가장 많이 태어나는 국가
2028년의 세계 RNA 표적 저분자 치료제 시장 : 부문 유형으로 가장 새로운 기회
2028년의 세계 RNA 표적 저분자 치료제 시장 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제25장 RNA 표적 저분자 치료제 시장 : 결론과 제안
결론
제안
제품
장소
가격
프로모션
사람들
제26장 부록
KSA
영문 목차
영문목차
RNA (ribonucleic acid) targeting small molecule therapeutics are a class of pharmaceutical compounds designed to specifically interact with RNA molecules within cells, modulating their function and activity to treat various diseases. RNA molecules play critical roles in gene expression, protein synthesis and cellular regulation and dysregulation of RNA function is implicated in numerous diseases, including cancer, genetic disorders, viral infections and neurodegenerative diseases.
The RNA targeting small molecule therapeutics market consists of sales of RNA targeting small molecule therapeutics by entities (organizations, sole traders or partnerships) that are engaged in the research, development and commercialization of therapeutic agents designed to interact with RNA through various mechanisms. These offerings include mRNA Translation modulators that affect the process by which messenger RNA (mRNA) is translated into proteins, RNA Splicing modifiers that alter the way in which RNA is spliced and various segments are joined together to form mature mRNA, Direct RNA Targeting molecules that bind directly to RNA to affect its function and other innovative approaches to RNA targeting.
The global RNA targeting small molecules therapeutics market was valued at $1,346.3 million in which grew till 2023 at a compound annual growth rate (CAGR) of more than 28.0%.
Increasing Incidence Of Neurological Disorders
The increasing incidence of neurological disorders propelled the growth of the RNA-targeting small molecule drug discovery market during the historic period. Neurological disorders refer to a wide range of conditions that affect the nervous system, including the brain, spinal cord and nerves, leading to impairments in movement, sensation, cognition, or other neurological functions. The increasing incidence of neurological disorders can be attributed to factors such as aging populations, environmental pollutants, lifestyle changes and improved diagnostic capabilities uncovering previously undetected cases. RNA-targeting small molecule drug discovery aids in addressing neurological disorders by developing therapeutics that specifically target RNA molecules associated with the pathology of these disorders, potentially offering novel treatments to modulate disease progression. According to the National Institutes of Health, a UK-based biomedical research agency, in 2019, neurological diseases comprised 3.8% of the global disease burden and 6.6% of Australia's total disease burden, contrasting with neurological conditions, which accounted for 8% of the burden in 2022. Therefore, the increasing incidence of neurological disorders drove the growth of the RNA targeting small molecule therapeutics market.
Key Players Embrace Startup Solutions In RNA Targeting Small Molecules Therapeutics
Companies in the RNA targeting small molecule therapeutics market are focusing on innovative startup solutions to optimize drug design and enhance RNA-targeted therapeutic development. These solutions facilitate target identification, molecular design and predictive modeling for efficacy and safety to contribute to the health and well-being of all people worldwide. For instance, in February 2024, AION Labs, an Israel-based venture hub for drug discovery and BioMed X, a Germany-based research institute, launched a global call for applications to identify computational biologists, biomedical scientists and inventors to form a new startup at AION Labs. It focuses on the development of an artificial intelligence (AI) and machine learning (ML) computational platform to identify functional regions in RNA that can be targeted with small molecules. RNA has traditionally been deemed unsuitable for small-molecule binding.
The global RNA targeting small molecule therapeutics market is highly concentrated, with a few large players operating in the market. The top ten competitors in the market made up to 98.9% of the total market in 2022.
RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global RNA targeting small molecules therapeutics market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for RNA targeting small molecules therapeutics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The RNA targeting small molecules therapeutics market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider RNA targeting small molecules therapeutics market; and compares it with other markets.
The report covers the following chapters
Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by therapeutic indication and by end-user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the RNA targeting small molecules therapeutics market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by therapeutic indication and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for RNA targeting small molecules therapeutics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Product: Antisense Oligonucleotides (ASOs); Small Interfering RNA (siRNA)
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; RNA targeting small molecules therapeutics indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1 Executive Summary
1.1 RNA Targeting Small Molecule Therapeutics - Market Attractiveness And Macro economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 RNA Targeting Small Molecules Therapeutics Market Definition And Segmentations
6.4 Market Segmentation By Product
6.4.1 Antisense Oligonucleotides (ASOs)
6.4.2 siRNA
6.5 Market Segmentation By Therapeutic Indication
6.5.1 Musculoskeletal Disorder
6.5.2 Neurodegenerative Diseases
6.5.3 Cardiovascular disease
6.5.4 Genito-Urinary
6.5.5 Other Therapeutic Indications
6.6 Market Segmentation By End-User
6.6.1 Hospitals
6.6.2 Research Laboratories
6.6.3 Pharmaceutical And Biotechnology Companies
6.6.4 Other End-Users
7 Major Market Trends
7.1 Strategic Collaboration Fueling RNA Targeting Small Molecules Therapeutics
7.2 Key Players Embrace Startup Solutions In RNA Targeting Small Molecules Therapeutics
7.3 Use Of Artificial Intelligence (AI) To Enhance Efficiency Of RNA Targeting Small Molecules During Drug Discovery
7.4 Partnerships Driving Innovation In RNA Targeting Small Molecules Therapeutics
7.5 Focus On Advancement In RNA Degrader Therapeutics Targeting For Various Medical Domains
7.6 Increased Focus On mRNA Small Molecule Drug Discovery
7.7 Development Of RNA Modulatory Drugs For Treating Neurological Diseases
10 Global RNA Targeting Small Molecules Therapeutics Market Segmentation
10.1 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.2 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.3 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11 RNA Targeting Small Molecules Therapeutics Market, Regional and Country Analysis
11.1 Global RNA Targeting Small Molecules Therapeutics Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.2 Global RNA Targeting Small Molecules Therapeutics Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.1.1 Market Overview
12.1.2 Region Information
12.1.3 Market Information
12.1.4 Background Information
12.1.5 Government Initiatives
12.1.6 Regulations
12.1.7 Regulatory Bodies
12.1.8 Major Associations
12.1.9 Taxes Levied
12.1.10 Corporate Tax Structure
12.1.11 Investments
12.1.12 Major Companies
12.2 Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.3 Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific RNA targeting Small Molecules Therapeutics Market: Country Analysis
12.6 China Market
12.7 Summary
12.7.1 Market Overview
12.7.2 Country Information
12.7.3 Market Information
12.7.4 Background Information
12.7.5 Government Initiatives
12.7.6 Regulations
12.7.7 Regulatory Bodies
12.7.8 Major Associations
12.7.9 Taxes Levied
12.7.10 Corporate Tax Structure
12.7.11 Investments
12.7.12 Major Companies
12.8 China RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.9 China RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.10 China RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.11 India Market
12.12 India RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.13 India RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.14 India RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.15 Japan Market
12.16 Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.18 Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.19 Australia Market
12.20 Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.22 Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.26 Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.30 South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.1.1 Market Overview
13.1.2 Region Information
13.1.3 Market Information
13.1.4 Background Information
13.1.5 Government Initiatives
13.1.6 Regulations
13.1.7 Regulatory Bodies
13.1.8 Major Associations
13.1.9 Taxes Levied
13.1.10 Corporate Tax Structure
13.1.11 Investments
13.1.12 Major Companies
13.2 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.3 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe RNA Targeting Small Molecules Therapeutics Market: Country Analysis
13.6 UK Market
13.7 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.8 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.9 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.10 Germany Market
13.11 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.12 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.13 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.14 France Market
13.15 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.16 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.17 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.18 Italy Market
13.19 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.20 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.21 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.22 Spain Market
13.23 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.24 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.25 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.1.1 Market Overview
14.1.2 Region Information
14.1.3 Market Information
14.1.4 Background Information
14.1.5 Government Initiatives
14.1.6 Regulations
14.1.7 Regulatory Bodies
14.1.8 Major Associations
14.1.9 Taxes Levied
14.1.10 Corporate Tax Structure
14.1.11 Major Companies
14.2 Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.3 Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe RNA targeting Small Molecules Therapeutics Market: Country Analysis
14.6 Russia Market
14.7 Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.8 Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15 North America Market
15.1 Summary
15.1.1 Market Overview
15.1.2 Region Information
15.1.3 Market Information
15.1.4 Background Information
15.1.5 Government Initiatives
15.1.6 Regulations
15.1.7 Regulatory Bodies
15.1.8 Major Associations
15.1.9 Taxes Levied
15.1.10 Corporate Tax Structure
15.1.11 Investments
15.1.12 Major Companies
15.2 North America RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.3 North America RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.4 North America RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.5 North America RNA targeting Small Molecules Therapeutics Market: Country Analysis
15.6 USA Market
15.7 Summary
15.7.1 Market Overview
15.7.2 Country Information
15.7.3 Market Information
15.7.4 Background Information
15.7.5 Government Initiatives
15.7.6 Regulations
15.7.7 Regulatory Bodies
15.7.8 Major Associations
15.7.9 Taxes Levied
15.7.10 Corporate Tax Structure
15.7.11 Investments
15.7.12 Major Companies
15.8 USA RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.9 USA RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.10 USA RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.11 Canada Market
15.12 Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.14 Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16 South America Market
16.1 Summary
16.1.1 Market Overview
16.1.2 Region Information
16.1.3 Market Information
16.1.4 Background Information
16.1.5 Government Initiatives
16.1.6 Regulations
16.1.7 Regulatory Bodies
16.1.8 Major Associations
16.1.9 Taxes Levied
16.1.10 Corporate Tax Structure
16.1.11 Investments
16.1.12 Major Companies
16.2 South America RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.3 South America RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.4 South America RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.5 South America RNA targeting Small Molecules Therapeutics Market: Country Analysis
16.6 Brazil Market
16.7 Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.8 Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.1.1 Market Overview
17.1.2 Region Information
17.1.3 Market Information
17.1.4 Background Information
17.1.5 Government Initiatives
17.1.6 Regulations
17.1.7 Regulatory Bodies
17.1.8 Major Associations
17.1.9 Taxes Levied
17.1.10 Corporate Tax Structure
17.1.11 Investments
17.1.12 Major Companies
17.2 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.3 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18 Africa Market
18.1 Summary
18.2 Market Overview
18.2.1 Region Information
18.2.2 Market Information
18.2.3 Background Information
18.2.4 Government Initiatives
18.2.5 Regulations
18.2.6 Regulatory Bodies
18.2.7 Major Associations
18.2.8 Taxes Levied
18.2.9 Corporate Tax Structure
18.2.10 Major Companies
18.3 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.5 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape And Company Profiles
19.1 Company Profiles
19.2 Ionis Pharmaceuticals
19.2.1 Company Overview
19.2.2 Products And Services
19.2.3 Business Strategy
19.2.4 Financial performance
19.3 Alnylam Pharmaceuticals
19.3.1 Company Overview
19.3.2 Products And Services
19.3.3 Business Strategy
19.3.4 Financial performance
19.4 Sarepta Therapeutics
19.4.1 Company Overview
19.4.2 Products And Services
19.4.3 Business Strategy
19.4.4 Financial performance
19.5 Jazz Pharmaceuticals
19.5.1 Company Overview
19.5.2 Products And Services
19.5.3 Financial performance
19.6 Novartis
19.6.1 Company Overview
19.6.2 Products And Services
19.6.3 Business Strategy
19.6.4 Financial performance
20 RNA Targeting Small Molecules Therapeutics Market Other Major And Innovative Companies
20.1 NS Pharma
20.1.1 Company Overview
20.1.2 Products And Services
20.2 Arrakis Therapeutics
20.2.1 Company Overview
20.2.2 Products And Services
20.3 PTC Therapeutics
20.3.1 Company Overview
20.3.2 Products And Services
20.4 Anima Biotech Inc.
20.4.1 Company Overview
20.4.2 Products And Services
20.5 Ribometrix
20.5.1 Company Overview
20.5.2 Products And Services
20.6 Skyhawk Therapeutics Inc.
20.6.1 Company Overview
20.6.2 Products And Services
20.7 STORM Therapeutics Ltd.
20.7.1 Company Overview
20.7.2 Products And Services
20.8 Accent Therapeutics
20.8.1 Company Overview
20.8.2 Products And Services
20.9 Promega Corporation
20.9.1 Company Overview
20.9.2 Products And Services
20.10 Bayer AG
20.10.1 Company Overview
20.10.2 Products And Services
20.11 Arrowhead Pharmaceuticals Inc.
20.11.1 Company Overview
20.11.2 Products And Services
20.12 Abivax SA
20.12.1 Company Overview
20.12.2 Products And Services
20.13 AC Immune SA
20.13.1 Company Overview
20.13.2 Products And Services
20.14 Remix Therapeutics
20.14.1 Company Overview
20.14.2 Products And Services
20.15 858 Therapeutics
20.15.1 Company Overview
20.15.2 Products And Services
21 Competitive Benchmarking
22 Competitive Dashboard
23 Key Mergers And Acquisitions
23.1 Novo Nordisk Acquire DiceRNA Pharmaceuticals
23.2 Sanofi's Acquired Translate Bio
24 Opportunities And Strategies
24.1 Global RNA Targeting Small Molecules Therapeutics Market In 2028 - Countries Type Most New Opportunities
24.2 Global RNA Targeting Small Molecules Therapeutics Market In 2028 - Segments Type Most New Opportunities
24.3 Global RNA Targeting Small Molecules Therapeutics Market In 2028 - Growth Strategies
24.3.1 Market Trend Based Strategies
24.3.2 Competitor Strategies
25 RNA Targeting Small Molecules Therapeutics Market, Conclusions And Recommendations
